Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
The Weed Whacker from Odd.Bot can be utilized via its Robot-as-a-Service offering and can be hired to clean any field of 10+ hectare. The intelligent robot -or robots- can detect both the weeds and crops already in an early stage and autonomously remove the weeds mechanically, specifically in the crop rows and in between the crops. Its biggest differentiators: sustainability: an alternative for (potential) harmful chemicals versatility: the spacing between the crops may vary resilience: it is highly adaptive and lightweight, which reduces soil compaction
Developer of autonomous greenhouse food production and indoor agriculture robots designed to automate tasks for food production in greenhouse horticulture sector industries. The company specializes in developing harvest and crop-handling robots and artificial intelligence-robotic harvester systems for indoor farming and eliminating factors like climate change and food security pressure, enabling farmers with a controlled climate and protection from the changes outside to get better yields with less land usage.
Qu & Co is a developer of quantum-computational software focused on creating algorithms tailored for optimizing specialty chemicals, pharmaceuticals, and functional materials. The company's team of highly skilled quantum developers collaborates closely with clients and academic advisors to design innovative quantum algorithms and translate them into effective software solutions. Qu & Co's offerings enhance in-house discovery and optimization processes by advancing quantum-computational chemistry methods, seamlessly integrating with existing workflows in chemistry and material science. This enables clients in the pharmaceutical and other industries to conduct complex chemistry and multiphysics simulations on emerging quantum processors.
AMT Medical BV has developed a minimal invasive medical device for heart bypass surgery. The AMT Heart Bypass System is based on the ELANA bypass, technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team of the UMCU. The technique is designed to make the traditional heart bypass procedures faster, safer, easier and less invasive for the patient.The product has been fully developed, production process has been designed, all pre-clinical trials have finished, a clinical multi-center trial will commence late 2019, early 2020.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.
QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel.
Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment.
It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.
VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.
Hardt Global Mobility, founded in 2016 and based in Delft, the Netherlands, specializes in the design and development of high-speed transportation systems. The company focuses on creating capsules that travel through vacuum tubes at speeds of up to 1,200 km/h. This innovative mode of transportation aims to enhance connectivity and accessibility, ultimately improving individual freedom and quality of life. By offering a fast and efficient means of travel, Hardt Global Mobility seeks to transform the way people move, connecting communities and making the world more accessible.
N2 Applied is a Norwegian technology company focused on innovative solutions for nitrogen fertilizer production directly on farms. Established in 2010 and headquartered in Oslo, the company has developed a method that allows livestock farmers to convert liquid organic substrates, such as manure and biogas digestate, into fertilizer by extracting nitrogen from the air. This process not only enhances the nitrogen content of the substrate but also mitigates ammonia loss and lowers greenhouse gas emissions. N2 Applied's technology promotes resource efficiency and cost savings for farmers by facilitating local fertilizer production, thus eliminating the need for long supply chains and reliance on fossil-based chemical fertilizers. The company's scalable system contributes to a circular farming model, offering additional benefits such as reductions in methane and ammonia emissions, as well as minimizing odors. N2 Applied operates a test center in Norway and has branches in the Netherlands and the UK, positioning itself within the realms of livestock farming, organic agriculture, and sustainable practices.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Microsure B.V., founded in 2016 and based in Son, Netherlands, specializes in the development of advanced robotic systems for microsurgery. The company's flagship product, MUSA, is designed to assist surgeons in performing intricate procedures, including lymphatic surgery, free flap surgery, and hand surgery. The Microsure motion stabilizer system enhances surgical precision and control, addressing the physical limitations faced by microsurgeons. This technology aims to improve the quality of microsurgical procedures, thus expanding treatment options for patients. The system has demonstrated its efficacy in clinical trials, successfully facilitating microsurgical operations for lymphedema at Maastricht UMC+. Microsure is focused on accelerating the market introduction and sales of its innovative surgical systems.
Delmic B.V., based in Delft, the Netherlands, specializes in manufacturing correlative light and electron microscopy solutions aimed at advancing life and materials science research. The company’s primary products include SECOM, which integrates fluorescence and electron microscopy; SPARC, a high-performance cathodoluminescence detection system; and Delphi, a combined fluorescence and scanning electron microscope. Delmic also develops software designed to facilitate navigation within its integrated microscopy systems. Founded in 2010, the company is committed to providing effective and user-friendly tools that enhance research capabilities, enabling researchers and organizations to gain insights more efficiently.
Plant-e is a pioneering company that specializes in harnessing the power of living plants to generate electricity. Founded in 2009 as a spin-off from Wageningen University, the company focuses on developing technology that enables power generation without harming the plants. Utilizing plant-microbial fuel cells, Plant-e captures electrons from the soil and converts them into electrical energy. This innovative approach allows for the creation of power sources from green roofs, wetlands, and rice paddies, effectively transforming them into sustainable energy providers. Marjolein Helder, who has been the CEO since her PhD graduation in 2012, leads the company, while David Strik continues to bridge the gap between scientific research and product development.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
At Quantib we come to work every day to help physicians solve the hardest challenges they face when diagnosing patients. Our smart software analyzes medical images to unravel secrets hidden to the naked eye. Are you excited to learn more about how artificial intelligence techniques can move healthcare forward and help our marketing department tell this story to the world? We’d love for you to join our tight team of 22 conquering the medical world with deep learning software.
Onera B.V. specializes in providing sleep diagnostic solutions aimed at diagnosing sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and based in Eindhoven, the Netherlands, the company employs innovative sleep diagnostic patch systems that collect and analyze sleep data to facilitate accurate diagnoses. These systems are designed to be comfortable and user-friendly, akin to wearing a band-aid, making them accessible for patients. Onera B.V. is a spin-off of imec, a leading research center in nanoelectronics and digital technology, and focuses on advancing sleep medicine through its breakthrough solutions. With a mission to improve the health and quality of life for individuals suffering from sleep-related ailments, Onera aims to provide essential diagnostic services that address the needs of millions worldwide.
Ventinova Medical, founded in 2013, focuses on the development and marketing of innovative medical devices for airway management and patient ventilation. The company specializes in creating single-use ventilation devices designed to control both inspiration and expiration during artificial airflow, actively assisting in the removal of gases from the lungs. This unique approach enhances patient recovery, particularly in critical situations where blood flow and oxygen saturation are compromised. Ventinova aims to revolutionize traditional ventilation practices by leveraging advanced technology and extensive medical expertise to deliver solutions that exceed current standards in the medical field.
Ventinova Medical, founded in 2013, focuses on the development and marketing of innovative medical devices for airway management and patient ventilation. The company specializes in creating single-use ventilation devices designed to control both inspiration and expiration during artificial airflow, actively assisting in the removal of gases from the lungs. This unique approach enhances patient recovery, particularly in critical situations where blood flow and oxygen saturation are compromised. Ventinova aims to revolutionize traditional ventilation practices by leveraging advanced technology and extensive medical expertise to deliver solutions that exceed current standards in the medical field.
Hiber is a company based in Amsterdam, founded in 2016, that specializes in satellite broadband services. The company offers a nano-satellite platform, known as Hiberband®, which is designed to provide low-cost Internet of Things (IoT) data connectivity for sensors across remote locations globally. Hiber's technology facilitates easy, low-power network access, allowing users to monitor and gather data from various environments, including water wells, agricultural fields, and transportation systems. The platform enables the transmission of small data packages, delivering actionable insights from anywhere in the world, thus transforming how connectivity and monitoring are approached in diverse sectors.
Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.